In this session, Sharon reflects on what the collective term ‘direct to consumer tests (DTC)’ might include and encompass – and on how, when (and why) these might be encountered in NHS general practice. Drawing on her experience as a GP, Sharon uses fictional vignettes to illustrate examples of this interface, and consider potential impacts for individuals and services. Sharon explores the potential for DTC testing, for example in empowering individuals, supporting conversations with clinicians, and informing next steps and care pathways. Alongside this, she draws out potential pitfalls and harms, including gaps in evidence and the potential for adverse impacts on health inequities. Throughout, Sharon considers what evidence and resources might be needed (or could help) smooth this journey, to optimise potential and minimise risks. Dr Sharon Dixon is a GP partner and NIHR Doctoral Research Fellow, NDPHCS, Oxford. Her DPhil is developing knowledge and resources to improve care for teenagers experiencing period pain. Sharon’s qualitative research includes exploring primary care perspectives on supporting care for communities affected by female genital mutilation, domestic violence, safeguarding, endometriosis, and women’s health. She has undertaken research into experiences of uro-gynaecology, using foetal Doppler devices outside medical settings, and research equity. She conducted a priority-setting partnership project exploring areas where better technology could enable women’s health. She is interested in experiences of delivering and receiving care in general practice. This talk was recorded at our event ‘Direct-to-Consumer Medical Testing: Exploring Opportunities & Challenges’ which took place at St Anne’s College, University of Oxford on Tuesday 5th May 2026.

Watch Now